Dr. Barry Dworkin

Health Canada approves Ozempic to reduce kidney deterioration in people with diabetes

Medical Mythbusting Commentary for August 27, 2025

Source:
Health Canada approves Ozempic to reduce kidney deterioration in people with diabetes

Related posts:

  1. The decision to use cholesterol-lowering statins requires full cardiovascular risk assessment
  2. Diabetes drug in short supply in U.S. (but not in Canada) after celebrities, influencers touted its weight-loss benefits.
  3. Ozempic and similar drugs linked to gastrointestinal conditions: B.C. researchers. Already known but needs context about rarity of some of the side effects versus the beneficial health outcomes when assessing overall risk of its use.
  4. Popular weight loss and diabetes drugs linked to increased risk of rare form of blindness. Study authors state that causality is not established. The health benefits of controlling diabetes, reduced heart, liver, kidney, and brain disease need to be considered with its use.